Ardmore, PA, United States of America

Jimish Mehta

This inventor holds 1 USPTO granted patent. Top assignee: Pathai, Inc.. Active years: 2026.


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jimish Mehta: Innovator in Predictive Healthcare Technology

Introduction

Jimish Mehta is an accomplished inventor based in Ardmore, PA (US). He has made significant contributions to the field of healthcare technology, particularly in the area of predictive analytics for disease management. His innovative work focuses on improving the understanding and treatment of ulcerative colitis.

Latest Patents

Jimish holds a patent for "Systems and methods for predicting disease severity in ulcerative colitis." This patent describes a method, system, or non-transitory computer-readable storage medium for training models to predict ulcerative colitis (UC) severity based on human-interpretable image features extracted from whole-slide images. The process involves accessing a plurality of annotated whole-slide images associated with UC patients, extracting human-interpretable image features, and training a statistical model to predict UC severity.

Career Highlights

Jimish is currently employed at Pathai, Inc., where he applies his expertise in predictive modeling and healthcare technology. His work is instrumental in advancing the capabilities of medical imaging and improving patient outcomes through data-driven insights.

Collaborations

Jimish collaborates with talented professionals such as Fedaa Najdawi and Kathleen Sucipto, contributing to a dynamic team focused on innovative healthcare solutions.

Conclusion

Jimish Mehta's contributions to predictive healthcare technology exemplify the impact of innovation in improving disease management. His work continues to pave the way for advancements in medical research and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…